Suppr超能文献

用于神经性疼痛的凝胶的最新进展

Recent Progress in Gels for Neuropathic Pain.

作者信息

Pușcașu Ciprian, Zanfirescu Anca, Negreș Simona

机构信息

Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania.

出版信息

Gels. 2023 May 16;9(5):417. doi: 10.3390/gels9050417.

Abstract

Neuropathic pain is a complex and debilitating condition that affects millions of people worldwide. While several treatment options are available, they often have limited efficacy and are associated with adverse effects. In recent years, gels have emerged as a promising option for the treatment of neuropathic pain. Inclusion of various nanocarriers, such as cubosomes and niosomes, into gels results in pharmaceutical forms with higher drug stability and increased drug penetration into tissues compared to products currently marketed for the treatment of neuropathic pain. Furthermore, these compounds usually provide sustained drug release and are biocompatible and biodegradable, which makes them a safe option for drug delivery. The purpose of this narrative review was to provide a comprehensive analysis of the current state of the field and identify potential directions for future research in the development of effective and safe gels for the treatment of neuropathic pain, ultimately improving the quality of life for patients suffering from neuropathic pain.

摘要

神经性疼痛是一种复杂且使人衰弱的病症,影响着全球数百万人。虽然有几种治疗选择,但它们的疗效往往有限,且伴有不良反应。近年来,凝胶已成为治疗神经性疼痛的一种有前景的选择。与目前市场上用于治疗神经性疼痛的产品相比,将各种纳米载体(如立方液晶和非离子表面活性剂囊泡)纳入凝胶中可形成具有更高药物稳定性且药物向组织渗透增加的药物剂型。此外,这些化合物通常能提供药物的持续释放,并且具有生物相容性和可生物降解性,这使其成为药物递送的安全选择。本叙述性综述的目的是对该领域的现状进行全面分析,并确定在开发用于治疗神经性疼痛的有效且安全的凝胶方面未来研究的潜在方向,最终改善患有神经性疼痛患者的生活质量。

相似文献

1
Recent Progress in Gels for Neuropathic Pain.
Gels. 2023 May 16;9(5):417. doi: 10.3390/gels9050417.
2
Combination pharmacotherapy for the treatment of neuropathic pain in adults.
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD008943. doi: 10.1002/14651858.CD008943.pub2.
4
5
Nortriptyline for neuropathic pain in adults.
Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD011209. doi: 10.1002/14651858.CD011209.pub2.
6
Treatment of neuropathic pain: an overview of recent guidelines.
Am J Med. 2009 Oct;122(10 Suppl):S22-32. doi: 10.1016/j.amjmed.2009.04.007.
8
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2.
9
10

引用本文的文献

1
Lower Extremity Targeted Muscle Reinnervation for Mononeuropathy in Nonamputation Patients: Techniques and Tips.
Plast Reconstr Surg Glob Open. 2025 Aug 4;13(8):e7000. doi: 10.1097/GOX.0000000000007000. eCollection 2025 Aug.
3
Characterization and Evaluation of the Cytotoxicity of Pregabalin Gels for Oral Application.
Pharmaceuticals (Basel). 2024 Sep 4;17(9):1168. doi: 10.3390/ph17091168.

本文引用的文献

1
Prevalence and Risk Factor Profiles for Chronic Axonal Polyneuropathy in the General Population.
Neurology. 2022 Nov 14;99(20):e2234-e2240. doi: 10.1212/WNL.0000000000201168.
2
Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls.
J Clin Med. 2022 May 26;11(11):3002. doi: 10.3390/jcm11113002.
3
Preparation and Evaluation of Hydrogel Film Containing Tramadol for Reduction of Peripheral Neuropathic Pain.
J Pharm Sci. 2023 Jan;112(1):132-137. doi: 10.1016/j.xphs.2022.05.013. Epub 2022 May 20.
8
Prevalence and treatment of neuropathic pain diagnoses among U.S. nursing home residents.
Pain. 2022 Jul 1;163(7):1370-1377. doi: 10.1097/j.pain.0000000000002525. Epub 2021 Oct 26.
9
Baclofen therapeutics, toxicity, and withdrawal: A narrative review.
SAGE Open Med. 2021 Jun 3;9:20503121211022197. doi: 10.1177/20503121211022197. eCollection 2021.
10
Combination gel of 2% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain - a case report of pain control success.
Rev Esp Anestesiol Reanim (Engl Ed). 2021 May;68(5):293-296. doi: 10.1016/j.redare.2020.05.023. Epub 2021 May 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验